https://adisinsight.springer.com/trials/700052781?error=cookies_not_supported&code=618ca92d-9558-4f3c-9632-4ba37925d8bb
A Phase 2 Study of LY2605541 Compared With Insulin Glargine in the Treatment of Type 1 Diabetes...
This non-inferiority trial compared the efficacy and tolerability of insulin peglispro [LY 2605541] and insulin glargine in patients with type 1 diabetes